Physician profile
Jennifer E Frank
NPI 1639158181
$4,460.64
in general payments reported to CMS, 2019-2025
8 companies · $24.76 in 2025
The $24.76 reported for 2025 was less than what a typical Adult Medicine provider received nationally (typical 2025 total: $127).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,093 · 2020: $460 · 2021: $782 · 2022: $392 · 2023: $330 · 2024: $378 · 2025: $24.76.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $733.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $732.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $2,213.62 | 2019-2025 | Sunlenca, Biktarvy |
| Viiv Healthcare Company | $1,061.73 | 2019-2024 | Apretude |
| Merck Sharp & Dohme LLC | $378.82 | 2019-2023 | Delstrigo |
| Janssen Products, LP | $299.41 | 2019-2021 | |
| Janssen Biotech, INC. | $261.66 | 2019-2021 | |
| Theratechnologies INC. | $125.00 | 2019 | |
| Janssen Scientific Affairs, LLC | $90.75 | 2019 | |
| Lilly USA, LLC | $29.65 | 2024 | Mounjaro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Frank listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.